Abstract:BACKGROUND. Glycogen synthase kinase 3 (GSK-3) has been regarded as a potential therapeutic target for multiple human cancers. We previously reported that suppression of GSK-3 activity with lithium chloride (LiCl) or small chemical inhibitors impaired cellular DNA synthesis and reduced cell proliferation in prostate cancer cells. Therefore, in this study, we extended this in vitro findings to in vivo settings in order to establish a proof of concept that inhibition of GSK-3 activity is feasible in suppressing tumor growth of prostate cancer in vivo. METHODS. In this study, we used three GSK-3 inhibitors, LiCl, TDZD-8, and L803-mts, which are structurally unrelated and non-ATP competitive. Human prostate cancer cell lines PC-3 and C4-2 were used for nude mouse xenograft models. The autochthonous transgenic prostate cancer TRAMP mice were used for testing GSK-3 inhibitor's effect on tumor development. Anti-Ki-67 and BrdU immunohistochemistry was used to determine cell proliferation. The pE2F-TA-LUC (E2F-LUC) luciferase reporter assay and gene specific small interferencing RNA technique were used to examine C/EBP involvement in GSK-3 inhibitor-induced E2F-1 suppression. RESULTS. Using mouse xenograft models, we demonstrated that LiCl and TDZD-8 significantly suppressed tumor development and growth of subcutaneous xenografts derived from human prostate cancer cells. Similarly, in the TRAMP mice, TDZD-8 and L803-mts reduced the incidence and tumor burden in the prostate lobes. Consistent with our previous in vitro findings, GSK-3 inhibitors significantly reduced BrdU incorporation and Ki67-positive cells in xenograft tumors and mouse cancerous prostates compared to the control. Further analysis revealed that following GSK-3 inhibition, C/EBP alpha, a negative cell cycle regulator, was remarkably accumulated in xenograft tumors or in cultured prostate cancer cells. Meanwhile, knocking down C/EBP alpha expression abolished GSK-3 inhibition-induced suppression of E2F1 transactivation, suggesting that C/EBP alpha accumulation is involved in GSK-3 inhibition-induced anti-tumor effect. CONCLUSION. Taken together, these results suggest that GSK-3 inhibition has the potential as a therapeutic strategy for prostate cancer intervention, although further pre-clinical and clinical testing are desirable. Prostate 71: 835-845, 2011. (C) 2010 Wiley-Liss, Inc.

Silence of ClC‐3 Chloride Channel Inhibits Cell Proliferation and the Cell Cycle Via G1/S Phase Arrest in Rat Basilar Arterial Smooth Muscle Cells

ClC-2 knockdown prevents cerebrovascular remodeling via inhibition of the Wnt/β-catenin signaling pathway

Low Chloride–Regulated ClC-5 Contributes to Arterial Smooth Muscle Cell Proliferation and Cerebrovascular Remodeling

INHIBITION OF SIGNAL TRANSDUCTION PATHWAYS OF ENDOTHELIN-1-INDUCED PROLIFERATION OF VASCULAR SMOOTH MUSCLE CELLS BY NITRIC OXIDE

[Estradiol Regulates the Expression of Small Conductance Ca(2)+ Activated K(+) Channel 3 in Rat Colonic Smooth Muscle Cells in an Estrogen Receptor Α-Dependent Manner].

Downregulation of Cited 1 suppresses cell proliferation by inducing G 2 / M arrest of the cell cycle in non-small-cell lung cancer cell lines

Stimulatory effect of chemokine-like factor 1 on the growth of rat vascular smooth muscle cells

Regulation of Cell Proliferation by Intermediate-Conductance Ca2+-Activated Potassium and Volume-Sensitive Chloride Channels in Mouse Mesenchymal Stem Cells

Cell Cycle-Dependent Expression of Potassium Channels and Cell Proliferation in Rat Mesenchymal Stem Cells from Bone Marrow.

Decrease of Intracellular Chloride Concentration Promotes Endothelial Cell Inflammation by Activating Nuclear Factor-κB Pathway

RNA interference-mediated secretory clusterin gene silencing inhibits proliferation and promotes apoptosis of human non-small cell lung cancer cells.

Effect of endothelin-1 on the proliferation and phenotypic transformation of vascular smooth muscle cells in rat

The Activation of P38 MAPK Limits the Abnormal Proliferation of Vascular Smooth Muscle Cells Induced by High Sodium Concentrations

Endothelin-1 promoted proliferation of vascular smooth muscle cell through pathway of extracellular signal-regulated kinase and cyclin D1.

Suppression of Glycogen Synthase Kinase 3 Activity Reduces Tumor Growth of Prostate Cancer in Vivo.

An Expanded Biological Repertoire for Ins(3,4,5,6)P4 Through Its Modulation of ClC-3 Function

Cbx 3 Inhibits Vascular Smooth Muscle Cell Proliferation , Migration and Neointima Formation Running Title : Cbx 3 in VSMC functions and neointima formation

Effects of Chemokine-Like Factor 1 on the Proliferation and Apoptosis of Human Vascular Smooth Muscle Cell

Suppression of CLC-3 chloride channel reduces the aggressiveness of glioma through inhibiting nuclear factor-κB pathway.

Effects of C-myc Gene Silencing on Interleukin-1Β-induced Rat Chondrocyte Cell Proliferation, Apoptosis and Cytokine Expression

1010 MONOCYTE CHEMOATTRACTANT PROTEIN-1 MEDIATES ANGIOTENSIN II-INDUCED VASCULAR SMOOTH MUSCLE CELL PROLIFERATION VIA SAPK/JNK AND ERK1/2